full record print

Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma

author
Jueliger, Simone
Lyons, John
Cannito, Sara
Pata, Illar
Pata, Pille
Školnaja, Marianna
statement of authorship
Simone Jueliger, John Lyons, Sara Cannito, Illar Pata, Pille Pata, Marianna Shkolnaya, Oriana Lo Re, Marion Peyrou, Francesc Villarroya, Valerio Pazienza, Francesca Rappa, Francesco Cappello, Mohammad Azab, Pietro Taverna, and Manlio Vinciguerra
source
Epigenetics
publisher
journal volume number month
vol. 11, 10
year of publication
pages
p. 709-720 : ill
url
ISSN
1559-2294
notes
Bibliogr.: 45 ref
Open Access
Open Access
scientific publication
teaduspublikatsioon
language
inglise
subject term
keyword
decitabine
DNA methylation
guadecitabine
hepatocellular carcinoma (HCC)
histone macroH2A1
steatohepatitis
Jueliger, S., Lyons, J., Cannito, S., Pata, I., Pata, P., Školnaja, M. et al. Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma // Epigenetics (2016) vol. 11, 10, p. 709-720 : ill. https://doi.org/10.1080/15592294.2016.1214781